Ribozyme treatment of diseases or conditions related to levels of NF-&kgr;B
US6410224B1 · kind B1 · utility
37Cited by
6References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 23, 1996 |
| Grant date | Jun 25, 2002 |
| Priority date | — |
| Expiry date | Dec 23, 2016 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/3535
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Enzymatic RNA molecules which cleave rel A mRNA.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.